In vivo cell kinetics studies of the duodenum during and after healing of cysteamine‐induced duodenal ulcer in rats using bromodeoxyuridine incorporation

SHIANN PAN, YUKINORI OKAZAKI, TADAYOSHI TAKEMOTO

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The present study investigated the defect of duodenal defence responsible for the tendency of recurrence of duodenal ulcer. Male Wistar rats were treated with cysteamine‐HCl subcutaneously to induce duodenal ulcer, and bromodeoxyuridine (BrdU) was given intraperitoneally 1 h before laparotomy. Serial tissue sections and immunocytochemical staining of BrdU were done to study the cell kinetics during and after healing. Deep ulcers developed in the proximal part of the duodenum 24 h after cysteamine injection, and the ulcer was replaced by scar tissue 1 week later. BrdU‐labelling index of normal duodenal mucosa in control rats was 30–34%. On the peripheral part of the regenerative mucosa, BrdU‐labelling index increased from 1.5% to 26–27%, 1–4 weeks after injection and remained at this level thereafter. On the central part, except the most central area, the labelling index remained at 0% until 3 weeks, and was 15% 6 weeks after cysteamine treatment. It never achieved the level seen in control normal mucosa. The labelling rate of fibrous cells in scar tissue decreased from 28% to nearly 0% 1–4 weeks after the injection. It is concluded that both the ulcer scar and the regenerative mucosa do not achieve a mature state in the initial scarred stage; they need more time to reach a relatively mature condition. Moreover, the regenerative mucosa will be the weak, easily damaged part of the duodenum.

Original languageEnglish
Pages (from-to)281-287
Number of pages7
JournalJournal of Gastroenterology and Hepatology
Volume5
Issue number3
DOIs
Publication statusPublished - Jan 1 1990

Fingerprint

Bromodeoxyuridine
Duodenal Ulcer
Duodenum
Mucous Membrane
Ulcer
Cicatrix
Cysteamine
Injections
Laparotomy
Wistar Rats
Staining and Labeling
Recurrence

Keywords

  • anti‐bromodeoxyuridine antibody
  • bromodeoxyuridine
  • cysteamine‐HCl
  • experimental duodenal ulcer.
  • Key words:

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

In vivo cell kinetics studies of the duodenum during and after healing of cysteamine‐induced duodenal ulcer in rats using bromodeoxyuridine incorporation. / PAN, SHIANN; OKAZAKI, YUKINORI; TAKEMOTO, TADAYOSHI.

In: Journal of Gastroenterology and Hepatology, Vol. 5, No. 3, 01.01.1990, p. 281-287.

Research output: Contribution to journalArticle

@article{c0c24de7be3649359ae074e44538f170,
title = "In vivo cell kinetics studies of the duodenum during and after healing of cysteamine‐induced duodenal ulcer in rats using bromodeoxyuridine incorporation",
abstract = "The present study investigated the defect of duodenal defence responsible for the tendency of recurrence of duodenal ulcer. Male Wistar rats were treated with cysteamine‐HCl subcutaneously to induce duodenal ulcer, and bromodeoxyuridine (BrdU) was given intraperitoneally 1 h before laparotomy. Serial tissue sections and immunocytochemical staining of BrdU were done to study the cell kinetics during and after healing. Deep ulcers developed in the proximal part of the duodenum 24 h after cysteamine injection, and the ulcer was replaced by scar tissue 1 week later. BrdU‐labelling index of normal duodenal mucosa in control rats was 30–34{\%}. On the peripheral part of the regenerative mucosa, BrdU‐labelling index increased from 1.5{\%} to 26–27{\%}, 1–4 weeks after injection and remained at this level thereafter. On the central part, except the most central area, the labelling index remained at 0{\%} until 3 weeks, and was 15{\%} 6 weeks after cysteamine treatment. It never achieved the level seen in control normal mucosa. The labelling rate of fibrous cells in scar tissue decreased from 28{\%} to nearly 0{\%} 1–4 weeks after the injection. It is concluded that both the ulcer scar and the regenerative mucosa do not achieve a mature state in the initial scarred stage; they need more time to reach a relatively mature condition. Moreover, the regenerative mucosa will be the weak, easily damaged part of the duodenum.",
keywords = "anti‐bromodeoxyuridine antibody, bromodeoxyuridine, cysteamine‐HCl, experimental duodenal ulcer., Key words:",
author = "SHIANN PAN and YUKINORI OKAZAKI and TADAYOSHI TAKEMOTO",
year = "1990",
month = "1",
day = "1",
doi = "10.1111/j.1440-1746.1990.tb01630.x",
language = "English",
volume = "5",
pages = "281--287",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - In vivo cell kinetics studies of the duodenum during and after healing of cysteamine‐induced duodenal ulcer in rats using bromodeoxyuridine incorporation

AU - PAN, SHIANN

AU - OKAZAKI, YUKINORI

AU - TAKEMOTO, TADAYOSHI

PY - 1990/1/1

Y1 - 1990/1/1

N2 - The present study investigated the defect of duodenal defence responsible for the tendency of recurrence of duodenal ulcer. Male Wistar rats were treated with cysteamine‐HCl subcutaneously to induce duodenal ulcer, and bromodeoxyuridine (BrdU) was given intraperitoneally 1 h before laparotomy. Serial tissue sections and immunocytochemical staining of BrdU were done to study the cell kinetics during and after healing. Deep ulcers developed in the proximal part of the duodenum 24 h after cysteamine injection, and the ulcer was replaced by scar tissue 1 week later. BrdU‐labelling index of normal duodenal mucosa in control rats was 30–34%. On the peripheral part of the regenerative mucosa, BrdU‐labelling index increased from 1.5% to 26–27%, 1–4 weeks after injection and remained at this level thereafter. On the central part, except the most central area, the labelling index remained at 0% until 3 weeks, and was 15% 6 weeks after cysteamine treatment. It never achieved the level seen in control normal mucosa. The labelling rate of fibrous cells in scar tissue decreased from 28% to nearly 0% 1–4 weeks after the injection. It is concluded that both the ulcer scar and the regenerative mucosa do not achieve a mature state in the initial scarred stage; they need more time to reach a relatively mature condition. Moreover, the regenerative mucosa will be the weak, easily damaged part of the duodenum.

AB - The present study investigated the defect of duodenal defence responsible for the tendency of recurrence of duodenal ulcer. Male Wistar rats were treated with cysteamine‐HCl subcutaneously to induce duodenal ulcer, and bromodeoxyuridine (BrdU) was given intraperitoneally 1 h before laparotomy. Serial tissue sections and immunocytochemical staining of BrdU were done to study the cell kinetics during and after healing. Deep ulcers developed in the proximal part of the duodenum 24 h after cysteamine injection, and the ulcer was replaced by scar tissue 1 week later. BrdU‐labelling index of normal duodenal mucosa in control rats was 30–34%. On the peripheral part of the regenerative mucosa, BrdU‐labelling index increased from 1.5% to 26–27%, 1–4 weeks after injection and remained at this level thereafter. On the central part, except the most central area, the labelling index remained at 0% until 3 weeks, and was 15% 6 weeks after cysteamine treatment. It never achieved the level seen in control normal mucosa. The labelling rate of fibrous cells in scar tissue decreased from 28% to nearly 0% 1–4 weeks after the injection. It is concluded that both the ulcer scar and the regenerative mucosa do not achieve a mature state in the initial scarred stage; they need more time to reach a relatively mature condition. Moreover, the regenerative mucosa will be the weak, easily damaged part of the duodenum.

KW - anti‐bromodeoxyuridine antibody

KW - bromodeoxyuridine

KW - cysteamine‐HCl

KW - experimental duodenal ulcer.

KW - Key words:

UR - http://www.scopus.com/inward/record.url?scp=0025149154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025149154&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.1990.tb01630.x

DO - 10.1111/j.1440-1746.1990.tb01630.x

M3 - Article

C2 - 2103411

AN - SCOPUS:0025149154

VL - 5

SP - 281

EP - 287

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 3

ER -